Compare FENC & SI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FENC | SI |
|---|---|---|
| Founded | 1996 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.4M | 269.1M |
| IPO Year | 2010 | N/A |
| Metric | FENC | SI |
|---|---|---|
| Price | $6.50 | $13.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $14.50 | ★ $20.80 |
| AVG Volume (30 Days) | ★ 133.5K | 60.1K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $44,642,000.00 | N/A |
| Revenue This Year | $65.12 | $39.59 |
| Revenue Next Year | $41.08 | $31.37 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.65 | $10.92 |
| 52 Week High | $9.92 | $17.23 |
| Indicator | FENC | SI |
|---|---|---|
| Relative Strength Index (RSI) | 47.05 | 46.95 |
| Support Level | $5.65 | $13.47 |
| Resistance Level | $8.09 | $13.63 |
| Average True Range (ATR) | 0.34 | 0.86 |
| MACD | 0.04 | -0.16 |
| Stochastic Oscillator | 48.51 | 43.24 |
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System.